3D-QSAR, design, molecular docking and dynamics simulation studies of novel 6-hydroxybenzothiazole-2-carboxamides as potentially potent and selective monoamine oxidase B inhibitors. [PDF]
Xie D +5 more
europepmc +1 more source
Design, Synthesis, Antifungal Activity, and 3D-QSAR Study of Novel Quinoxaline-2-Oxyacetate Hydrazide. [PDF]
Teng P +5 more
europepmc +1 more source
Robust and predictive 3D-QSAR models for predicting the activities of novel oxadiazole derivatives as multifunctional anti-Alzheimer agents. [PDF]
Sun Y +6 more
europepmc +1 more source
2D/3D-QSAR Model Development Based on a Quinoline Pharmacophoric Core for the Inhibition of Plasmodium falciparum: An In Silico Approach with Experimental Validation. [PDF]
Lorca M +9 more
europepmc +1 more source
ACE inhibitors from <i>Suaeda salsa</i>: 3D-QSAR modeling, metabolomics, molecular docking and molecular dynamics simulations. [PDF]
Yue G, Gu H, Zhang K, Song Y, Hao Y.
europepmc +1 more source
Development and experimental validation of 3D QSAR models for the screening of thyroid peroxidase inhibitors using integrated methods of computational chemistry. [PDF]
Rudresh BB +6 more
europepmc +1 more source
3D-QSAR and Molecular Dynamics Study of Isoxazole Derivatives to Identify the Structural Requirements for Farnesoid X Receptor (FXR) Agonists. [PDF]
Yan D +5 more
europepmc +1 more source
3D-QSAR Modeling on 2-Pyrimidine Carbohydrazides as Utrophin Modulators for the Treatment of Duchenne Muscular Dystrophy by Combining CoMFA, CoMSIA, and Molecular Docking Studies. [PDF]
Mahmoudzadeh Laki R, Pourbasheer E.
europepmc +1 more source
Evaluation of antibacterial, cytotoxicity, and apoptosis activity of novel chromene-sulfonamide hybrids synthesized under solvent-free conditions and 3D-QSAR modeling studies. [PDF]
Ghomashi S +7 more
europepmc +1 more source
Virtual screening of acetylcholinesterase inhibitors through pharmacophore-based 3D-QSAR modeling, ADMET, molecular docking, and MD simulation studies. [PDF]
Kumar H, Datusalia AK, Khatik GL.
europepmc +1 more source

